Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Preclinical trials overview

In addition, tests for mutagenicity and carcinogenicity are not likely required for most biopharma-ceutical substances. The regulatory guidelines and industrial practices relating to biopharmaceuti-cal preclinical trials thus remain in an evolutionary mode, and each product is taken on a case-by-case basis. An overview of the main preclinical tests undertaken for a sample biopharmaceutical... [Pg.84]

This account has presented an overview of the new Bcr-Abl inhibitors in both preclinical and clinical development. While AMN107 and BMS-354825 have advanced to Phase II trials for the treatment of CML, it is frustrating from... [Pg.435]

See other pages where Preclinical trials overview is mentioned: [Pg.332]    [Pg.499]    [Pg.448]    [Pg.83]    [Pg.808]    [Pg.332]    [Pg.2493]    [Pg.104]    [Pg.208]    [Pg.367]    [Pg.189]   
See also in sourсe #XX -- [ Pg.137 , Pg.138 ]



SEARCH



Preclinical

Preclinical trial

© 2024 chempedia.info